Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033

Authors: Johan M Kros, Elisabeth Rushing, Aimé L Uwimana, Aurelio Hernández-Laín, Alex Michotte, Maysa Al-Hussaini, Franck Bielle, Christian Mawrin, Gianluca Marucci, C Mircea S Tesileanu, Roger Stupp, Brigitta Baumert, Martin van den Bent, Pim J French, Thierry Gorlia

Published: 2022-12-26

DOI: 10.1093/neuonc/noac282

Source: Full article

Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033

Abstract